Back to search

United Kingdom· GB-APID-11483011000001104

Thioridazine 25mg/5ml oral solution

A thioridazine product containing thioridazine, registered in United Kingdom by Special Order. The same ATC class is registered in 5 of our 19 countries.

ATC N05AC02

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedThioridazine 25mg/5ml oral solutionATCN05AC02REGISTER NO.GB-APID-1148301100000…PACKS LISTED0CHECKEDSeptember 13, 2026

Where it is registered

Thioridazine is registered in 5 of 19 countries.

Countries holding a registration under ATC N05AC02 (thioridazine), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 3 of them publish a price we can compare per daily dose

Thioridazine · ATC N05AC02

5 / 19 countries

  • Finlandprice
  • Germany
  • Norwayprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Thioridazine
Manufacturer
Special Order
Country
United Kingdom (GB)
ATC code
N05AC02
ATC class
Thioridazine
Defined daily dose
0.3 g, O
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

361 interactions on record for thioridazine.

Graded by severity as the source publishes them — 175 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Thioridazine · interactions on record

361 records

  • 175 severe
  • 177 moderate
  • 9 minor

Most severe, free to view

  • CimetidineA02BA01severe
  • PapaverineA03AD01severe
  • MetoclopramideA03FA01severe
  • CisaprideA03FA02severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Thioridazine in 4 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All thioridazine products

Authorised across Europe · EMA

The same active substance is authorised in 1 EEA country. Names it is sold under:

  • Germany · Thioridazin Neuraxpharm

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c32c14db-87ae-4896-8ff1-44efc77ef336
GET /v1/drugs/c32c14db-87ae-4896-8ff1-44efc77ef336?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "11483011000001104",
  "desc": "Thioridazine 25mg/5ml oral solution (Special Order)",
  "form": "Oral solution",
  "vpid": "42280111000001109",
  "source": "dmd",
  "vtm_id": "777745005",
  "strength": "5 mg",
  "substance": "Thioridazine",
  "ingredient": "Thioridazine hydrochloride",
  "supplier_code": "8286711000001104"
}

See everything about thioridazine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.